Search alternatives:
significant mean » significant main (Expand Search), significant green (Expand Search), significant gap (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant mean » significant main (Expand Search), significant green (Expand Search), significant gap (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
221
-
222
Fluctuation trend of the mean temperature index.
Published 2025“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”
-
223
Variation curve of the mean temperature index.
Published 2025“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”
-
224
-
225
-
226
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
227
-
228
-
229
-
230
Flow chart of experimental protocol.
Published 2024“…SBP showed an increasing trend, but this was not statistically significant (<i>p</i> = 0.108). Interestingly, we observed significant decreases in arterial stiffness and PWV in POST_VM when comparing with PRE_VM (<i>p</i><0.001 and <i>p</i><0.001, respectively). …”
-
231
A representative ultrasound axis image.
Published 2024“…SBP showed an increasing trend, but this was not statistically significant (<i>p</i> = 0.108). Interestingly, we observed significant decreases in arterial stiffness and PWV in POST_VM when comparing with PRE_VM (<i>p</i><0.001 and <i>p</i><0.001, respectively). …”
-
232
-
233
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
234
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
235
-
236
-
237
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
238
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
239
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
240
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: